-
June 18, 2019PREVIEW
Use of once-monthly erenumab (Aimovig—Amgen, Novartis) in patients with chronic migraine who overused medications resulted in a greater reduction in migraine days and acute migraine-specific...
-
April 30, 2019PREVIEW
People with multiple sclerosis (MS) who were prescribed high-efficacy disease-modifying therapies (DMTs) as initial therapy had better long-term outcomes than those prescribed moderate-efficacy...
-
March 12, 2019PREVIEW
Treatment of hypertension to systolic blood pressure (SBP) levels of less than 120 mm Hg did not result in a lower incidence of dementia, but did significantly reduce the risk of mild cognitive...
-
March 5, 2019PREVIEW
Patients with secondary progressive multiple sclerosis (MS), an advanced form of MS, who were treated with rituximab had significantly lower scores on the Expanded Disability Status Scale (EDSS)...
-
February 5, 2019PREVIEW
The risk of serious adverse skin reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is increased with use of antiepileptic drugs (AEDs) compared with non-AEDs,...
Pages
